Immunoglobulins, normal human ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
65Primary immunodeficiency1

65. Primary immunodeficiency


Clinical trials : 482 Drugs : 653 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 212
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2006-006745-13-IT
(EUCTR)
30/08/200701/08/2007A Multicenter Study of the Efficacy, Tolerability, Safety and Pharmacokinetics of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects with Primary Immunodeficiency - NDA Multicenter Study of the Efficacy, Tolerability, Safety and Pharmacokinetics of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects with Primary Immunodeficiency - ND PID (Primary Immunodeficiency)
MedDRA version: 6.1;Level: HLGT;Classification code 10021460
Product Name: IgPro20
Product Code: IgPro20
INN or Proposed INN: Immunoglobulins, normal human
CSL Behring AG (casa madre)NULLNot RecruitingFemale: yes
Male: yes
36United Kingdom;Germany;France;Spain;Italy;Poland;Sweden